↓ Skip to main content

Beta blockers for peripheral arterial disease

Overview of attention for article published in Cochrane database of systematic reviews, September 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
83 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Beta blockers for peripheral arterial disease
Published in
Cochrane database of systematic reviews, September 2013
DOI 10.1002/14651858.cd005508.pub3
Pubmed ID
Authors

Sharath Chandra Vikram Paravastu, Derick A Mendonca, Anthony Da Silva

Abstract

Beta (β) blockers are indicated for use in coronary artery disease (CAD). However, optimal therapy for people with CAD accompanied by intermittent claudication has been controversial because of the presumed peripheral haemodynamic consequences of beta blockers, leading to worsening symptoms of intermittent claudication. This is an update of a review first published in 2008.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 1%
Canada 1 1%
Unknown 81 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 18%
Student > Bachelor 10 12%
Student > Master 10 12%
Student > Ph. D. Student 9 11%
Other 5 6%
Other 16 19%
Unknown 18 22%
Readers by discipline Count As %
Medicine and Dentistry 28 34%
Nursing and Health Professions 10 12%
Pharmacology, Toxicology and Pharmaceutical Science 6 7%
Agricultural and Biological Sciences 4 5%
Psychology 3 4%
Other 6 7%
Unknown 26 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2020.
All research outputs
#8,274,606
of 15,335,820 outputs
Outputs from Cochrane database of systematic reviews
#8,584
of 11,169 outputs
Outputs of similar age
#58,151
of 133,915 outputs
Outputs of similar age from Cochrane database of systematic reviews
#81
of 119 outputs
Altmetric has tracked 15,335,820 research outputs across all sources so far. This one is in the 45th percentile – i.e., 45% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,169 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.9. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 133,915 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 119 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.